英诺赛科(02577.HK)：受托人从市场购买公司23.9万股H股
INNOSCIENCEINNOSCIENCE(HK:02577) Ge Long Hui·2025-11-05 14:08

Core Viewpoint - InnoCare Pharma (02577.HK) has adopted a share incentive plan for 2025, which involves the purchase of 239,000 H-shares for the benefit of eligible participants [1] Group 1 - The trustee has acquired a total of 239,000 H-shares from the market as part of the 2025 share incentive plan [1] - The shares are held in trust for the benefit of eligible participants as defined in the plan [1]